<DOC>
	<DOCNO>NCT00191009</DOCNO>
	<brief_summary>This study compare atomoxetine placebo take current standard Alzheimer 's Disease medication . The treatment take approximately 6 month hypothesize atomoxetine significantly improve cognitive performance compare placebo .</brief_summary>
	<brief_title>Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Patient present Alzheimer 's Disease base clinical history . Patient must Mini Mental Status Score 10 26 . Patient must reliable caregiver frequent daily contact patient . Patient must currently treat stable dose standard Alzheimer 's drug treatment least 3 month . Patients receive pharmacologic treatment ( cholinesterase inhibitor memantine ) Alzheimer 's Disease . Patients history past 5 year current evidence major psychiatric illness . Patients narrow angle glaucoma . Patients experience clinically significant urinary hesitancy retention assess physician .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>